Which statement about Narcan administration is true?

Study for the BIPC Substance Abuse and Disorders Exam. Challenge yourself with a variety of questions to enhance your knowledge and strengthen your preparation. Each question comes with hints and explanations to help you understand and retain crucial information.

Multiple Choice

Which statement about Narcan administration is true?

Explanation:
Naloxone reverses opioid toxicity by competing for opioid receptors, and its effect can wear off while opioids are still active in the body. Because some opioids last longer or are more potent (like long-acting or synthetic fentanyl-type opioids), a single dose may not provide full, lasting reversal. That’s why the statement that it may be repeated if indicated is true. In practice, naloxone can be given by several routes (intramuscular, intravenous, subcutaneous, or intranasal) and does not have to be given intravenously to work. It is not restricted to hospital settings, and clinicians and first responders commonly administer additional doses if symptoms return or respiration remains impaired after the first dose. Be aware that repeated dosing can precipitate withdrawal in opioid-dependent individuals, so monitoring and reassessment are important.

Naloxone reverses opioid toxicity by competing for opioid receptors, and its effect can wear off while opioids are still active in the body. Because some opioids last longer or are more potent (like long-acting or synthetic fentanyl-type opioids), a single dose may not provide full, lasting reversal. That’s why the statement that it may be repeated if indicated is true. In practice, naloxone can be given by several routes (intramuscular, intravenous, subcutaneous, or intranasal) and does not have to be given intravenously to work. It is not restricted to hospital settings, and clinicians and first responders commonly administer additional doses if symptoms return or respiration remains impaired after the first dose. Be aware that repeated dosing can precipitate withdrawal in opioid-dependent individuals, so monitoring and reassessment are important.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy